Table 1.
Clinical, pathological features and biochemical recurrence by pathological groups
| Variables | Groups by RPP pathology | P-value | ||||
|---|---|---|---|---|---|---|
| pT2/SM– | pT2/AM+ | CI | pT3a/SM– | pT3a/SM+ | ||
| Number of points | 186 | 12 | 35 | 19 | 14 | |
| Median PSA ng ml–1 (range) | 6.97 (1.3–37.6) | 6.5 (4.1–24.6) | 7.0 (4.1–60.6) | 7.49 (2.9–23.3) | 12.1 (3.8–39.5) | 0.004a |
| Gleason score | ||||||
| ⩽6 | 70 | 1 | 9 | 3 | 2 | 0.009b |
| 7 | 90 | 10 | 15 | 14 | 5 | |
| ⩾8 | 26 | 1 | 11 | 2 | 7 | |
| Number of BCR (%) | 15 (8) | 2 (16.7) | 10 (28.6) | 2 (10.5) | 7 (50) | |
| Adjusted HR versus capsular incision (95% Confidence Interval) | 0.312 (0.155–0.643) | 1.170 (0.446–3.758) | 1.0 | 0.697 (0.147–3.303) | 1.374 (1.158–4.063) | |
| P-value | <0.0001 | 0.614 | 0.318 | 0.044 | ||
Abbreviations: BCR, biochemical recurrence; CI, capsular incision; HR, Hazard ratio; PSA, Prostate-specific antigen.
a
Compared by Kruskal–Wallis test.
b
Compared by Fisher's exact test.